Publications by authors named "David Blythin"

Claim this Profile
D
Discovery of oxazole-based PDE4 inhibitors with picomolar potency.
Rongze Kuang, Ho-Jane Shue, Li Xiao, David J Blythin, Neng-Yang Shih

Bioorg Med Chem Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors.
Rongze Kuang, Ho-Jane Shue, David J Blythin, Neng-Yang Shih, Danlin Gu

Bioorg Med Chem Lett· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
Ho-Jane Shue, Xiao Chen, John H Schwerdt, Sunil Paliwal, David J Blythin

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic urea derivatives as potent NK1 selective antagonists.
Ho-Jane Shue, Xiao Chen, Neng-Yang Shih, David J Blythin, Sunil Paliwal

Bioorg Med Chem Lett· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonist.
Anandan Palani, Sherry Shapiro, John W Clader, William J Greenlee, David Blythin

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and NK(1)/NK(2) binding activities of a series of diacyl-substituted 2-arylpiperazines.
David J Blythin, Xiao Chen, John J Piwinski, Neng-Yang Shih, Ho-Jane Shue

Bioorg Med Chem Lett· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis